In a welcome move, Alcon saw its Relative Strength Rating rise from 68 to 71 on Tuesday.
IBD's unique RS Rating identifies market leadership by using a 1 (worst) to 99 (best) score that indicates how a stock's price action over the last 52 weeks stacks up against all the other stocks in our database.
History shows that the stocks that go on to make the biggest gains typically have an RS Rating of above 80 in the early stages of their moves. See if Alcon can continue to rebound and clear that threshold.
How To Invest In Stocks In Both Bull And Bear Markets
Alcon is trying to complete a consolidation with a 101.10 buy point. See if the stock can clear the breakout price in heavy trade.
While earnings-per-share growth decreased in the company's most recently reported quarter from 23% to 3%, sales rose 6%, up from 5% in the previous report.
The company earns the No. 15 rank among its peers in the Medical-Products industry group. Boston Scientific, Pro-Dex and Penumbra are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
